For respondents facing novel Federal Trade Commission theories, the lesson is that early engagement—not reflexive litigation—can yield outcomes that address regulatory concerns while preserving ...

This document provides information about the F-Tile Avalon® Streaming IP for PCI Express Configuration Intercept Interface (CII) interface. The document details an example design that demonstrates CII ...

WASHINGTON – The Federal Trade Commission (FTC) has secured a landmark settlement with one of the nation’s largest pharmacy benefit managers (PBMs), Express Scripts, Inc., and its affiliated entities ...

Cigna's top brass said that the company has anticipated a "clearing event" in the pharmacy benefit management industry, and that its new model aligns with regulators' push toward greater transparency.

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The MarketWatch News Department was not involved in the creation of this content. Settlement resolves FTC lawsuit alleging that Express Scripts' conduct resulted in artificially inflated insulin drug ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

FTC allegations centered on “Big 3” PBMs using anticompetitive rebating and affiliated-pharmacy channel dynamics to inflate insulin list prices and capture rebate and margin-driven revenues.

The Federal Trade Commission has agreed to what it called a “landmark” settlement with Express Scripts, allowing the company to bow out of the agency’s lawsuit against major pharmacy benefit managers ...